First-round
|
Mean agreement scores on
|
Definitions
|
86.6
|
4.0
|
4.0
|
4.7
|
0.7
|
0.8
|
Risk factors
|
81.9
|
3.8
|
4.0
|
4.6
|
0.8
|
0.8
|
Screening and diagnosis
|
81.9
|
3.7
|
4.1
|
4.7
|
1.0
|
0.8
|
Prevention
|
81.1
|
3.8
|
4.0
|
4.4
|
0.6
|
0.8
|
Long-term follow up in primary care
|
82.5
|
3.6
|
3.9
|
4.7
|
1.1
|
0.7
|
Second-round
|
Mean agreement scores on:
|
Management
|
83.0
|
3.8
|
4.1
|
4.9
|
1.1
|
0.8
|
Monitoring
|
84.1
|
3.7
|
4.0
|
4.6
|
0.9
|
0.7
|
Facilities
|
96.9
|
4.0
|
5.0
|
5.0
|
1.0
|
0.5
|
Surveillance
|
98.0
|
4.0
|
4.5
|
5.0
|
1.0
|
0.5
|
First-round statements that achieved consensus in the second-round
|
High-risk preeclampsia: previous history of systemic lupus erythematosus.
|
72.9
|
3.0
|
4.0
|
4.3
|
1.3
|
0.9
|
This test is recommended as a baseline reference for women with a high risk of preeclampsia: creatinine
|
70.8
|
3.0
|
4.0
|
5.0
|
2.0
|
1.0
|
A GP can prescribe low dose aspirin as prophylaxis for preeclampsia.
|
70.8
|
3.0
|
4.0
|
4.0
|
1.0
|
0.9
|
Aspirin 75-150 mg is given daily at bedtime
|
70.8
|
3.0
|
4.0
|
4.0
|
1.0
|
0.8
|
Third-round
|
Mean agreement scores on:
|
Hypertensive disorders of pregnancy (HDP) diagnosis flowchart.
|
86.5
|
4.0
|
4.0
|
4.0
|
0.0
|
0.8
|
HDP management pathways in primary care
|
83.8
|
4.0
|
4.0
|
5.0
|
1.0
|
1.0
|
Surveillance pathway for women with HDP in primary care.
|
86.5
|
4.0
|
4.0
|
5.0
|
1.0
|
0.8
|
First-round statement that achieved consensus in the third-round
|
This test is recommended as a baseline reference for women with high risk of preeclampsia: platelet count
|
70.8
|
3.0
|
4.0
|
4.0
|
1.0
|
1.0
|